Logo of Phnom Penh Post newspaper Phnom Penh Post - South Korean pharmas aim for Nasdaq

South Korean pharmas aim for Nasdaq

Content image - Phnom Penh Post
CoImmune, a joint venture between SCM LifeScience and Genexine, is preparing for an initial public offering (IPO) on the tech-heavy Nasdaq Composite. THE KOREA HERALD

South Korean pharmas aim for Nasdaq

South Korea’s pharmaceutical and biopharma companies are ramping up efforts to get listed on the Nasdaq market, hoping to follow in the footsteps of Korean e-commerce giant Coupang with their US market debut.

According to industry sources on April 1, CoImmune, a joint venture between SCM LifeScience and Genexine, is preparing for an initial public offering (IPO) on the tech-heavy Nasdaq Composite.

CoImmune’s appointment of biotechnology and finance expert Dr Edgardo Baracchini to the company’s board of directors in February was a move to speed up its IPO process, the sources added.

Founded in 2019, CoImmune is a biopharmaceutical company that develops personalised immunotherapies for cancer treatments. The company also has a cGMP manufacturing facility, those capable of supporting clinical studies from phase one through phase three.

GC LabCell, a manufacturer of cell therapy products in South Korea, is also pushing ahead with its US-based affiliate Artiva Biotherapeutics’ IPO.

Active discussions revolving around the Artiva Biotherapeutics IPO began in January when GC Lab Cell and its affiliate pulled off an exclusive collaboration and licence deal with Merck, or MSD, to transfer CAR-NK cell therapy technology in treating solid cancer, such as breast or prostate cancer.

Other reports suggested that bio-similar start-up company Aprogen has also been in discussions with Nomura Securities to look at options of entering the US stock market.

Aprogen is a venture enterprise founded in 2000 that has developed technologies in antibody engineering and recombinant protein engineering.

Other Korean companies that are considering IPOs in the US include Dong-A ST, Yuhan, Rokit Healthcare and L&K Biomed.

The industry sources said that local biohealth companies are hoping to get listed on the Nasdaq market to make inroads into the world’s largest drug market and to ramp up its market capitalisation.

An analyst at Samsung Securities said: “If listed on the Nasdaq market, local pharmaceutical companies could get an upper hand when entering the US market, and they could potentially gain a broader base of financing to pursue growth in the future.”

The US pharmaceutical market is currently valued at around 571 trillion won ($505 billion), accounting for some 40 per cent of the global market’s 1.418 quadrillion won.



  • Joy as Koh Ker Temple registered by UNESCO

    Cambodia's Koh Ker Temple archaeological site has been officially added to UNESCO’s World Heritage List, during the 45th session of the World Heritage Committee held in Riyadh, Saudi Arabia, on September 17. The ancient temple, also known as Lingapura or Chok Gargyar, is located in

  • Ream base allegations must end, urges official

    A senior government official urges an end to the allegations and suspicions surrounding the development of Cambodia’s Ream Naval Base, now that Prime Minister Hun Manet has addressed the issue on the floor of the 78th UN General Assembly (UNGA 78). Jean-Francois Tain, a geopolitical

  • Cambodia set to celebrate Koh Ker UNESCO listing

    To celebrate the inscription of the Koh Ker archaeological site on UNESCO’s World Heritage List, the Ministry of Cults and Religion has appealed to pagodas and places of worship to celebrate the achievement by ringing bells, shaking rattles and banging gongs on September 20. Venerable

  • CP denied registration documents by ministry

    The Ministry of Interior will not reissue registration documents to the Candlelight Party (CP). Following a September 21 meeting between ministry secretary of state Bun Honn and CP representatives, the ministry cited the fact that there is no relevant law which would authorise it to do

  • Cambodian diaspora laud Manet’s UN Assembly visit

    Members of the Cambodian diaspora are rallying in support of Prime Minister Hun Manet’s forthcoming visit to the 78th UN General Assembly (UNGA 78) in the US’ New York City this week. Their move is an apparent response to a recent call by self-exiled former

  • After three deferrals, Capital Gains Tax to take effect Jan 1, 2024

    The General Department of Taxation (GDT) will implement the Capital Gains Tax starting January 1, 2024 to after being deferred three times as industrial players warn that the implementation might have some negative impact on the property market growth, which is down due to the economic downturn.